COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Medical Oncology

• Publication date

  2011-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12032-010-9737-3PMID 21069476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study

  2012cited by this paper
• Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation.

  2010cited by this paper
• Relationship between cyclooxygenase‐2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up‐regulation and lymphangiogenesis in human breast cancer

  2010cited by this paper
• Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression.

  2010cited by this paper
• Survival time and prognostic factors of oral cancer in Ubon Ratchathani Cancer Center.

  2010cited by this paper
• Cationic polymer‐mediated small interfering RNA delivery for P‐glycoprotein down‐regulation in tumor cells

  2010cited by this paper
• Increased Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs: A Nationwide Case–Crossover Study

  2010cited by this paper
• [Reasons for recurrence and prognostic analysis of early stage squamous cell carcinoma of the oral tongue].

  2009cited by this paper
• Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis

  2009cited by this paper
• Cox-2 expression in ovarian malignancies: a review of the clinical aspects.

  2009cited by this paper
• Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.

  2009cited by this paper
• shRNA-targeted Cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells

  2008cited by this paper
• Cyclooxygenase-2 expression during immortalization and breast cancer progression (Cancer Research (2008) 68, (467-475))

  2008cited by this paper
• Cyclooxygenase-2 expression during immortalization and breast cancer progression.

  2008cited by this paper
• Expression of COX-2 in Stomach Carcinogenesis

  2008cited by this paper
• The Cyclooxygenase‐2 Selective Inhibitor Celecoxib Suppresses Proliferation and Invasiveness in the Human Oral Squamous Carcinoma

  2007cited by this paper
• [Significance of cyclooxygenase-2 as a chemotherapeutic target in hepatocellular carcinoma].

  2007cited by this paper
• Role of cyclooxygenase-2 in tumor progression and immune regulation in lung cancer.

  2007cited by this paper
• Tumor lymphangiogenesis and metastatic spread—New players begin to emerge

  2006cited by this paper
• Cyclo-oxygenase-2 over-expression is associated with human esophageal squamous cell carcinoma.

  2006cited by this paper
• [Treatment and prognostic analysis of 92 cases with advanced mobile tongue squamous cell carcinoma].

  2006cited by this paper
• Lymphangiogenesis in development and human disease

  2005cited by this paper
• Prognostic importance of COX-2 expression in patients with colorectal cancer.

  2005cited by this paper
• Cancer and cyclooxygenase-2 (COX-2) inhibition.

  2004cited by this paper
• Side effects of conventional nonsteroidal anti-inflammatory drugs and celecoxib: more similarities than differences.

  2004cited by this paper
• Cyclooxygenase-2 Induces EP1- and HER-2/Neu-Dependent Vascular Endothelial Growth Factor-C Up-Regulation

  2004cited by this paper
• Cancer and cyclooxygenase-2 (COX-2) inhibition.

  2004cited by this paper
• Lymphangiogenesis and tumor metastasis

  2003cited by this paper
• Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer

  2002cited by this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cited by this paper
• Is cyclooxygenase-2 the alpha and the omega in cancer?

  2000cited by this paper
• Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer.

  1999cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper

• Mucin 5AC is significantly upregulated in exosomes from the nasal lavage fluid and may promote the expression of COX-2, VEGF and MMP-9: an implication in nasal polyp pathogenesis.

  2021cites this paper
• Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential

  2021cites this paper
• Vascular Endothelial Growth Factor: A Translational View in Oral Non-Communicable Diseases

  2021cites this paper
• [Effects of silencing Rce1 in vitro on the invasion and migration of tongue carcinoma].

  2019cites this paper
• Effect of celecoxib on protein expression of FAK and Cx43 in DMBA induced rat tongue carcinoma cells.

  2019cites this paper
• Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma

  2019cites this paper
• Immunoexpression of VEGFR-3, but not the immunoexpression of VEGF-C or lymphatic density, is correlated with metastasis in lower lip squamous cell carcinoma.

  2017cites this paper
• HNSCC Biomarkers Derived from Key Processes of Cancerogenesis

  2016cites this paper
• Immunohistochemical predictors in squamous cell carcinoma of the tongue and floor of the mouth

  2016cites this paper
• Clinical significance of inflammatory mediators in the pathogenesis of oral cancer.

  2016cites this paper
• Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinoma

  2016cites this paper
• The genetic variant of COX-2 acts as a potential risk factor of colorectal cancer: evidence from a meta-analysis based on 13461 individuals

  2015cites this paper
• miR-26b is downregulated in human tongue squamous cell carcinoma and regulates cell proliferation and metastasis through a COX-2-dependent mechanism.

  2015cites this paper
• Cyclooxygenase-2 – An Imperative Prognostic Biomarker in Oral Squamous Cell Carcinoma- An Immunohistochemical Study

  2015cites this paper
• The prognostic value of immunohistochemical markers for oral tongue squamous cell carcinoma

  2015cites this paper
• Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer.

  2014cites this paper
• "CYCLOOXYGENASE-2" - A VIBRANT CHEMICAL MEDIATOR IN A PLETHORA OFORAL LESIONS

  2014cites this paper
• Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation

  2014cites this paper
• Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-c and lymph node metastasis in human oral tongue cancer.

  2014cites this paper
• Mechanisms Underlying Cancer Progression Caused by Ezrin Overexpression in Tongue Squamous Cell Carcinoma

  2013cites this paper
• Synergistic antitumor activity of reversine combined with aspirin in cervical carcinoma in vitro and in vivo

  2013cites this paper
• The Tumor Microenvironment Contribution to Development, Growth, Invasion and Metastasis of Head and Neck Squamous Cell Carcinomas

  2013cites this paper
• miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.

  2012cites this paper
• Arachidonic Acid Metabolism and Its Implication on Head and Neck Cancer

  2012cites this paper
• High expression levels of COX-2 and P300 are associated with unfavorable survival in laryngeal squamous cell carcinoma

  2012cites this paper
• Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression.

  2010cites this paper